Depo-Provera Lawsuit Update

Blog Highlights

• Kentucky women diagnosed with meningioma after multiple Depo-Provera injections may qualify for compensation.
• More than 2,100 Depo-Provera brain tumor cases are already pending in federal court as of February 2026.
• You have only one year from diagnosis in Kentucky to file a lawsuit

Women who have used Depo-Provera birth control could qualify for the Depo-Provera lawsuit in Kentucky. As of February 2026, there are over 2,100 cases in the multidistrict litigation (MDL).

With more and more women coming forward, the mass tort is gaining momentum. Understanding the legal nuances of these cases and evaluating your chances of getting compensation requires a professional legal approach.

The mass tort team from the Bryant Law Center shares the latest information about Depo-Provera brain tumor lawsuits.

What Is Depo-Provera and Who Uses It?

Depo-Provera is a prescription birth control shot. It contains depot medroxyprogesterone acetate (DMPA), which is a synthetic form of progesterone. Pfizer manufactures it under brand names Depo-Provera and Depo-SubQ Provera 104.

Many Kentucky women chose the birth control injection because of its convenience. There is no daily pill to remember. For years, patients trusted that this medication was safe when used as directed.

The Link Between Depo-Provera and Brain Tumors (Meningiomas)

Recent scientific research has raised concerns about a connection between long-term Depo-Provera use and tumors, called meningiomas, that form in the lining of the brain or spinal cord.

Meningiomas are often hormone-sensitive. Since Depo-Provera contains a potent progestin, researchers began studying whether prolonged exposure could increase tumor risk.

After learning about the connection, thousands of women across the country, including Kentucky, have started filing lawsuits against Pfizer because it failed to warn them about the risk.

What the Research Shows: Understanding the Risk

Several studies* published in peer-reviewed medical journals have reported a significantly increased risk of meningioma in women who used high-dose injectable progestins. Plaintiffs argue that earlier warnings could have helped women make informed decisions about their birth control options.

Not every woman who uses Depo-Provera will develop a tumor. These lawsuits focus on women who used the medication repeatedly and later faced a confirmed meningioma diagnosis.

Current Status of Depo-Provera Lawsuits in 2026

Depo-Provera cases have been consolidated into a federal multidistrict litigation (MDL No. 3140) in the U.S. District Court for the Northern District of Florida. As of February 2026, more than 2,100 cases are pending.

In December 2025, the FDA approved a new warning about meningioma on Depo-Provera’s U.S. label. Because of this update, the court asked both sides to submit additional arguments before issuing a ruling.

This decision is important. If the judge agrees with Pfizer’s federal preemption argument, many of the cases could be dismissed. If she rejects it, the lawsuits will move forward to the next phase, which includes expert testimony about whether Depo-Provera can cause meningioma.

Who Qualifies to File a Depo-Provera Lawsuit?

You may qualify for a Depo-Provera claim if:

• You received at least four Depo-Provera, Depo-SubQ Provera 104, or approved generic injections
• You were diagnosed with a cranial or spinal meningioma

Eligibility can also depend on timing. In Kentucky, the statute of limitations only gives you one year after receiving a diagnosis to file a lawsuit.

Symptoms of Meningioma You Shouldn’t Ignore

Symptoms of meningioma vary depending on tumor location. They may include:

• Persistent headaches
• Vision changes or double vision
• Seizures
• Hearing loss
• Memory or concentration problems
• Weakness in extremities

If you have experienced these symptoms after using Depo-Provera, you must seek medical care immediately.

What Compensation Is Available in These Cases?

A successful meningioma lawsuit may provide compensation for:

• Medical expenses (surgery, radiation, imaging)
• Lost wages or reduced earning capacity
• Pain and suffering
• Ongoing care needs

Settlement amounts depend on factors like the extent of the health-related consequences and long-term impact on daily life.

How the Lawsuit Process Works for Mass Tort Cases

Mass tort litigation allows many similar cases to move forward while preserving each woman’s individual claim.

The process can include:

• Case review and record collection
• Filing into the MDL
• Evidence development and expert review
• Potential settlement negotiations
• Trial (if the case doesn’t settle)

While this may seem complicated, you will not need to travel frequently. Most of the legal work is handled by your attorney.

Start Your Free Depo-Provera Case Evaluation Today 

Bryant Law Center specializes in mass tort litigation and understands complex pharmaceutical cases. A skilled pharmaceutical mass tort attorney knows exactly how to navigate such cases and achieve the best possible results.

You trusted a medication. If that trust was misplaced, you deserve answers.

Contact Bryant Law Center today for a free case evaluation. We handle all Depo-Provera cases on a contingency fee basis.

Image credit: // Shutterstock // ADragan